Navigation Links
New X-ray technique targets terrorists and tumors
Date:11/30/2007

Scientists at The University of Manchester have developed a new x-ray technique that could be used to detect hidden explosives, drugs and human cancers more effectively.

Professor Robert Cernik and colleagues from The School of Materials have built a prototype colour 3D X-ray system that allows material at each point of an image to be clearly identified.

The innovative work is reported in the latest issue of The Journal of the Royal Society Interface and is published online today, Wednesday 28 November 2007.

The technique developed by the Manchester scientists is known as tomographic energy dispersive diffraction imaging or TEDDI.

It harnesses all the wavelengths present in an x-ray beam to create probing 3D pictures.

The technique improves on existing methods by allowing detailed images to be created with one very simple scanning motion.

The method makes use of advanced detector and collimator engineering pioneered at Daresbury Laboratory, Rutherford Appleton Laboratory and The University of Cambridge.

Scientists believe this advanced engineering will reduce the time taken to create a sample scan from hours to just a few minutes.

This shorter period would eliminate the problem of radiation damage, allowing biopsy samples to be studied and normal tissue types to be distinguished from abnormal.

Professor Cernik said: We have demonstrated a new prototype X-ray imaging system that has exciting possibilities across a wide range of disciplines including medicine, security scanning and aerospace engineering.

Current imaging systems such as spiral CAT scanners do not use all the information contained in the X-ray beam. We use all the wavelengths present to give a colour X-ray image. This extra information can be used to fingerprint the material present at each point in a 3D image.

The TEDDI method is highly applicable to biomaterials, with the possibility of specific ti
'/>"/>

Contact: Alex Waddington
alex.waddington@manchester.ac.uk
01-612-758-387
University of Manchester
Source:Eurekalert

Page: 1 2

Related biology news :

1. New technique can be breakthrough for early cancer diagnosis
2. University of Leicester scientists discover technique to help friendly bacteria
3. New technique reveals subtle force-induced changes in biomolecules conformation
4. New magnetic separation technique might detect multiple pathogens at once
5. New technique captures chemical reactions in a single living cell at unprecedented resolution
6. Software Techniques Inc. Selects M2SYS Fingerprint Software to Meet Continuous Growth and Demand for Desktop Biometric Time & Attendance Solutions
7. Nicotinic receptors may be important targets for treatment of multiple addictions
8. Central targets may hinder wider waste management objectives
9. UIC researchers find promising new targets for antibiotics
10. HU scientist finds way to catch terrorists red-handed
11. Invasion of the brain tumors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
(Date:7/2/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/km7m5t/natural_language ... "Natural Language Processing Market by Type (Rule-Based, Statistical, ... Image Recognition) - Worldwide Forecast to 2020" ... vendors occupying the market are 3M, Apple, Dolbey ... Solutions, SAS Institute Inc., Verint Systems among various ...
(Date:6/29/2015)... , June 24, 2015 ... addition of the "Latin America Biomedical Sensors Market ... their offering. The Latin America Biomedical Sensors ... a CAGR of 2.04% over the period 2014-2020 ... are adaptable to the genetic formulation of each individual. ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2Latin America Biomedical Sensors Market Report 2015-2020 2
... scientists studying macrophages, the biological cells that spring from white ... have discovered how these policemen differentiate between friend and foe. ... in the March 10 edition of the Journal of Cell ... able to turn off rogue macrophages that are the root ...
... being a model of social co-operation, the ant world is ... the way to the top, according to scientists from the ... thought to work together for the benefit of the colony ... Leeds Faculty of Biological Sciences has found evidence to shatter ...
... ethanol as a fuel alternative will worsen pollution in the ... and aquatic life, according to University of British Columbia researcher ... Donner and Chris Kucharik of the University of Wisconsin quantify ... pollution in a waterway. Their findings will appear in the ...
Cached Biology News:Policing cells demand ID to tell friend from foe, say University of Pennsylvania cell engineers 2Royal corruption is rife in the ant world 2US rush to produce corn-based ethanol will worsen 'dead zone' in Gulf of Mexico: UBC study 2
(Date:7/28/2015)... July 21, 2015 Research and Markets ... the "Biomedical Refrigerators and Freezers Market - ... Forecast 2014 - 2022" report to their ... and freezers market has been segmented based on ... banks, and others. The others segment includes applications ...
(Date:7/28/2015)... , July 28, 2015  Moerae Matrix ... Phase 1 clinical trial with MMI-0100, a first-in-class ... being developed for pulmonary disorders characterized by inflammation ... United Kingdom , is a double-blind, ... evaluating the safety and tolerability of MMI-0100 when ...
(Date:7/28/2015)... ZIONA, Israel , July 28, ... OTC:CQPTY), a regenerative medicine company utilizing its proprietary ... announced that Shomrat Shurtz has been appointed Senior ...      (Photo: http://photos.prnewswire.com/prnh/20150728/246955 ) ... years of experience in marketing, regulatory and business ...
(Date:7/27/2015)... ... July 27, 2015 , ... This is ... report provides a basic overview of the industry including definitions, classifications, applications and ... including development trends, competitive landscape analysis, and key regions development status. Development policies ...
Breaking Biology Technology:Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 2Biomedical Refrigerators and Freezers Market Report - Global Industry Analysis 2015 3Moerae Initiates Lipopolysaccharide (LPS) Challenge Study of Inhaled MMI-0100 for Pulmonary Disease Following Encouraging Safety and Tolerability Observed in Single Ascending Dose Phase 1 Study 2CollPlant Names Shomrat Shurtz Senior Director of Business Development 22015 Biophotonics Market Global Research 22015 Biophotonics Market Global Research 3
... June 16 Anesiva,Inc. (Nasdaq: ANSV ) today ... executive officer and a member of the company,s board ... P. McLaughlin,who resigned as chief executive officer and member ... remaining a consultant to the,company., "Michael is the ...
... position in the life sciences ... ... has announced today an,agreement to acquire Recombinant Capital, Inc. (Recap), a ... is Recap,s unique database that provides more than 1,500,subscribers with access ...
... of Company,s Cancer ... Therapy Product, ... of Kathy Blum as the company,s,new Chief Executive Officer. With extensive ... as global experience with,start-ups and Fortune 500 organizations, Ms. Blum brings ...
Cached Biology Technology:Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors 2Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors 3Deloitte Agrees to Acquire Recombinant Capital, A Leading Life Sciences Subscription Database and Advisory Services Firm 2Applied Computational Technologies Appoints a New CEO 2
... The potential applications for the use of ... gene expression via the RNA interference,(RNAi) pathway ... and molecular biology fields. siRNA for experimental ... or enzymatically, and then transfected into the ...
... Schistosomal glutathione-S-transferase (GST) is commonly used ... in E. coli (1). The GSTTag sequence ... and in some cases the solubility of ... soluble, properly folded form, GSTTag fusion proteins ...
Acetylcholinesterase (human brain, AChE)...
C1-inhibitor (C1-INH)...
Biology Products: